CDRH Director to leave FDA, Deputy Center Director for Transformation Tarver to become Acting CDRH Director

Jeff Shuren, director of medical devices at the Food and Drug Administration (FDA), is retiring from a 15-year tenure with the agency. Michelle Tarver, deputy center director for transformation, will become the Center for Devices and Radiological Health (CDRH)’s acting director next week.

The transition will be effective on July 28, and Shuren will officially leave the FDA later this year following his assistance in the transition of the center director emeritus, according to FDA Commissioner Robert Califf…

Read the news here.

Source: CDRH Director to leave FDA, Deputy Center Director for Transformation Tarver to become Acting CDRH Director. By Silvia Oakland, July 26, 2024. GovCIO.

🔊 Listen to Story